The SmartBP Management Suite is an evidence-based clinical decision-support tool designed to help healthcare professionals accurately classify blood pressure, assess cardiovascular risk, and generate personalized treatment and target recommendations. By integrating current guideline logic with patient-specific factors, the tool supports precise, efficient, and standardized hypertension care.
This calculator simplifies the stepwise management of hypertension by transforming raw blood pressure readings into actionable clinical guidance. It helps clinicians identify hypertension stages, determine treatment thresholds, and set individualized BP targets to improve long-term cardiovascular outcomes.
Users enter key clinical parameters such as:
Systolic and diastolic blood pressure
Patient age
Presence of diabetes
Chronic kidney disease status
Established ASCVD
Cardiovascular risk factors
Current antihypertensive therapy (optional)
The system applies guideline-based algorithms (e.g., ACC/AHA, ESC/ISH adaptable logic) to generate a structured management plan.
BP classification (normal, elevated, stage 1, stage 2, etc.)
Cardiovascular risk context
Treatment initiation recommendations
Preferred first-line drug classes
Combination therapy guidance
Personalized BP target
Follow-up interval suggestions
Lifestyle modification advice
Automated BP classification
Guideline-aligned treatment logic
Personalized BP targets
Risk-factor–aware recommendations
Stepwise therapy escalation
Quick clinical summary output
Mobile and bedside optimized
Primary care and specialist friendly
General physicians
Cardiologists
Internists
Family medicine clinicians
Nurse practitioners
Clinical pharmacists
Medical residents and students
Telemedicine platforms
Standardizes hypertension management
Speeds clinical decision-making
Improves guideline adherence
Supports individualized care
Reduces therapeutic inertia
Enhances cardiovascular risk reduction
This calculator is intended for educational and clinical decision-support purposes only. Final treatment decisions should always be individualized and aligned with current clinical guidelines and institutional protocols.